Ignite Creation Date:
2025-12-24 @ 11:31 PM
Ignite Modification Date:
2026-01-09 @ 12:41 PM
Study NCT ID:
NCT05198856
Status:
UNKNOWN
Last Update Posted:
2022-01-20
First Post:
2021-11-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Thalidomide Combined With Chemotherapy and Monotherapy for Maintenance Treatment for Her2-negative Advanced GC
Sponsor:
Qilu Hospital of Shandong University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
HOPE2021-Thal-AGC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None